X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10505) 10505
Book Review (1545) 1545
Publication (1387) 1387
Book Chapter (70) 70
Government Document (60) 60
Conference Proceeding (35) 35
Magazine Article (14) 14
Dissertation (11) 11
Trade Publication Article (4) 4
Data Set (3) 3
Book / eBook (2) 2
Newspaper Article (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9138) 9138
humans (8816) 8816
female (6734) 6734
breast neoplasms - genetics (4580) 4580
brca1 (4486) 4486
oncology (4479) 4479
breast cancer (4425) 4425
mutation (3942) 3942
brca1 protein - genetics (3899) 3899
cancer (3036) 3036
middle aged (2844) 2844
adult (2752) 2752
genetic aspects (2507) 2507
genes, brca1 (2416) 2416
ovarian neoplasms - genetics (2165) 2165
genetics & heredity (1998) 1998
genetic predisposition to disease (1912) 1912
brca1 protein (1904) 1904
brca2 protein - genetics (1883) 1883
ovarian cancer (1869) 1869
ovarian-cancer (1851) 1851
aged (1815) 1815
research (1610) 1610
risk factors (1581) 1581
animals (1544) 1544
genes (1525) 1525
brca1 protein - metabolism (1503) 1503
dna repair (1407) 1407
biochemistry & molecular biology (1405) 1405
brca2 protein (1382) 1382
male (1368) 1368
breast-cancer (1362) 1362
risk (1358) 1358
brca2 (1330) 1330
cell biology (1285) 1285
breast neoplasms - pathology (1265) 1265
genes, brca2 (1258) 1258
dna damage (1200) 1200
women (1166) 1166
mutations (1120) 1120
tumors (1091) 1091
gene mutations (1082) 1082
skin and connective tissue diseases (1070) 1070
genetics (1015) 1015
health aspects (984) 984
proteins (974) 974
mice (960) 960
analysis (945) 945
germ-line mutation (937) 937
genetic testing (917) 917
neoplasm proteins - genetics (917) 917
expression (916) 916
cell line, tumor (910) 910
gene expression (908) 908
gene (907) 907
dna (903) 903
article (899) 899
breast (887) 887
transcription factors - genetics (852) 852
prognosis (821) 821
homologous recombination (815) 815
breast neoplasms - metabolism (799) 799
deoxyribonucleic acid--dna (797) 797
medicine & public health (738) 738
heterozygote (728) 728
endocrine system diseases (703) 703
aged, 80 and over (676) 676
repair (671) 671
germline mutations (663) 663
pedigree (656) 656
gene expression regulation, neoplastic (655) 655
susceptibility (648) 648
dna mutational analysis (637) 637
protein (633) 633
genetic research (631) 631
breast neoplasms - epidemiology (629) 629
multidisciplinary sciences (624) 624
care and treatment (621) 621
cells (619) 619
chemotherapy (610) 610
families (594) 594
research article (585) 585
breast neoplasms - diagnosis (559) 559
carriers (542) 542
genomics (541) 541
phosphorylation (537) 537
survival (534) 534
cell cycle (533) 533
dna-binding proteins - genetics (524) 524
molecular sequence data (524) 524
carcinoma (522) 522
pathology (521) 521
polymerase chain reaction (521) 521
medicine (519) 519
oncology, experimental (509) 509
case-control studies (505) 505
genetic screening (505) 505
apoptosis (501) 501
base sequence (498) 498
phenotype (496) 496
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10381) 10381
Chinese (56) 56
French (47) 47
Japanese (47) 47
German (31) 31
Russian (25) 25
Polish (13) 13
Spanish (13) 13
Czech (8) 8
Dutch (7) 7
Bulgarian (6) 6
Hebrew (5) 5
Croatian (3) 3
Hungarian (2) 2
Italian (2) 2
Korean (2) 2
Latvian (2) 2
Portuguese (2) 2
Swedish (2) 2
Danish (1) 1
Persian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Koboldt, Daniel C and Fulton, Robert S and McLellan, Michael D and Schmidt, Heather and Kalicki-Veizer, Joelle and McMichael, Joshua F and Fulton, Lucinda L and Dooling, David J and Ding, Li and Mardis, Elaine R and Wilson, Richard K and Ally, Adrian and Balasundaram, Miruna and Butterfield, Yaron S. N and Carlsen, Rebecca and Carter, Candace and Chu, Andy and Chuah, Eric and Chun, Hye-Jung E and Coope, Robin J. N and Dhalla, Noreen and Guin, Ranabir and Hirst, Carrie and Hirst, Martin and Holt, Robert A and Lee, Darlene and Li, Haiyan I and Mayo, Michael and Moore, Richard A and Mungall, Andrew J and Pleasance, Erin and Robertson, A. Gordon and Schein, Jacqueline E and Shafiei, Arash and Sipahimalani, Payal and Slobodan, Jared R and Stoll, Dominik and Tam, Angela and Thiessen, Nina and Varhol, Richard J and Wye, Natasja and Zeng, Thomas and Zhao, Yongjun and Birol, Inanc and Jones, Steven J. M and Marra, Marco A and Cherniack, Andrew D and Saksena, Gordon and Onofrio, Robert C and Pho, Nam H and Carter, Scott L and Schumacher, Steven E and Tabak, Barbara and Hernandez, Bryan and Gentry, Jeff and Nguyen, Huy and Crenshaw, Andrew and Ardlie, Kristin and Beroukhim, Rameen and Winckler, Wendy and Getz, Gad and Gabriel, Stacey B and Meyerson, Matthew and Chin, Lynda and Kucherlapati, Raju and Hoadley, Katherine A and Auman, J. Todd and Fan, Cheng and Turman, Yidi J and Shi, Yan and Li, Ling and Topal, Michael D and He, Xiaping and Chao, Hann-Hsiang and Prat, Aleix and Silva, Grace O and Iglesia, Michael D and Zhao, Wei and Usary, Jerry and Berg, Jonathan S and Adams, Michael and Booker, Jessica and Wu, Junyuan and Gulabani, Anisha and Bodenheimer, Tom and Hoyle, Alan P and Simons, Janae V and Soloway, Matthew G and Mose, Lisle E and Jefferys, Stuart R and Balu, Saianand and Parker, Joel S and Hayes, D. Neil and Perou, Charles M and Malik, Simeen and Mahurkar, Swapna and Shen, Hui and Weisenberger, Daniel J and Triche Jr, Timothy and Lai, Phillip H and ... and Canc Genome Atlas Network and Cancer Genome Atlas Network and The Cancer Genome Atlas Network
Nature, ISSN 0028-0836, 10/2012, Volume 490, Issue 7418, pp. 61 - 70
We analysed primary breast cancers by genomic DNA copy number arrays, DNA methylation, exome sequencing, messenger RNA arrays, microRNA sequencing and... 
PATHWAYS | TARGET | BASAL-LIKE | SUPPRESSOR | PIK3CA GENE | SUBTYPES | MULTIDISCIPLINARY SCIENCES | HIGH-FREQUENCY | LUMINAL-B | CANCER | MUTATIONAL EVOLUTION | GATA3 Transcription Factor - genetics | Receptors, Estrogen - metabolism | Oligonucleotide Array Sequence Analysis | Genomics | Humans | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Gene Expression Profiling | Breast Neoplasms - metabolism | Ovarian Neoplasms - genetics | DNA Methylation | DNA Mutational Analysis | Female | Genes, BRCA1 | Genes, Neoplasm - genetics | Breast Neoplasms - classification | RNA, Messenger - genetics | Retinoblastoma Protein - metabolism | DNA Copy Number Variations - genetics | Genes, p53 - genetics | Mutation - genetics | Genetic Heterogeneity | Genome, Human - genetics | Phosphatidylinositol 3-Kinases - genetics | Exome - genetics | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Breast Neoplasms - pathology | Retinoblastoma Protein - genetics | Genes, erbB-2 - genetics | Proteomics | Protein Array Analysis | RNA, Neoplasm - genetics | MAP Kinase Kinase Kinase 1 - genetics | MicroRNAs - genetics | Breast tumors | Gene mutations | Oncology, Experimental | Genetic aspects | Research | Identification and classification | Cancer | Proteins | DNA methylation | Genetics | Breast cancer | Mutation | Index Medicus | Càncer de mama | Oncologia | Oncology | Gene expression | Expressió gènica | Genòmica
Journal Article
Cancer Cell, ISSN 1535-6108, 2007, Volume 11, Issue 2, pp. 103 - 105
Journal Article
Cancer, ISSN 0008-543X, 05/2017, Volume 123, Issue 10, pp. 1721 - 1730
Testing with a 25‐gene hereditary cancer panel more than doubled the number of women with a personal diagnosis of breast cancer identified as carrying a... 
hereditary breast and ovarian cancer | triple‐negative breast cancer | breast cancer type 1 | panel testing | ) | BRCA1 | BRCA2 | breast cancer type 1 (BRCA1) | triple-negative breast cancer | POPULATION | BRCA2 MUTATIONS | METAANALYSIS | VARIANTS | RISK | PREVALENCE | FAMILY-HISTORY | SUSCEPTIBILITY GENES | COWDEN-SYNDROME | ONCOLOGY | DIFFUSE GASTRIC-CANCER | Genetic Testing | Age Factors | Humans | Middle Aged | Young Adult | Checkpoint Kinase 2 - genetics | Tumor Suppressor Proteins - genetics | Aged, 80 and over | Genes, BRCA2 | Adult | Female | RNA Helicases - genetics | Lynch Syndrome II - genetics | Neoplastic Syndromes, Hereditary - genetics | Genes, BRCA1 | Nuclear Proteins - genetics | Fanconi Anemia Complementation Group N Protein | Hereditary Breast and Ovarian Cancer Syndrome - genetics | DNA-Binding Proteins - genetics | Fanconi Anemia Complementation Group Proteins | Breast Neoplasms - genetics | Triple Negative Breast Neoplasms - genetics | Aged | Ataxia Telangiectasia Mutated Proteins - genetics | Ubiquitin-Protein Ligases - genetics | Women | Breast cancer | Genetic aspects | Diagnosis | Research | Health aspects | Oncogenes | BRCA2 protein | CHK2 protein | Threonine | BRCA1 protein | Genes | Health risks | Protein C | Genetic screening | DNA helicase | Men | Breast | Ataxia | Ataxia telangiectasia mutated protein | Protein-serine/threonine kinase | Mutation | Health risk assessment | Age | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2017, Volume 35, Issue 10, pp. 1086 - 1095
Journal Article
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 20, pp. 3925 - 3932
In the current study, pathogenic germline mutations in cancer‐predisposing genes, predominantly involved in the DNA damage repair pathway, are found in a... 
prostate cancer | germline variants | multiple primary malignant neoplasms | genetic testing | gene panel | GENOMICS | ONCOLOGY | COLORECTAL-CANCER | DNA | HOXB13 G84E MUTATION | RISK | LYNCH SYNDROME | Humans | Middle Aged | Male | Mutation, Missense | Checkpoint Kinase 2 - genetics | Prostatic Neoplasms - genetics | DNA Mutational Analysis | Tumor Suppressor Proteins - genetics | Aged, 80 and over | Germ-Line Mutation | Adult | RNA Helicases - genetics | Neoplastic Syndromes, Hereditary - genetics | Neoplasms, Second Primary - genetics | Nuclear Proteins - genetics | Fanconi Anemia Complementation Group N Protein | Receptor, Fibroblast Growth Factor, Type 3 - genetics | Genetic Predisposition to Disease | Neoplastic Syndromes, Hereditary - diagnosis | DNA-Binding Proteins - genetics | Fanconi Anemia Complementation Group Proteins | Sequence Analysis, DNA | Homeodomain Proteins - genetics | MutL Protein Homolog 1 - genetics | Age of Onset | Aged | Ataxia Telangiectasia Mutated Proteins - genetics | BRCA2 Protein - genetics | Care and treatment | Genetic aspects | Research | Gene mutations | Genetic variation | Prostate cancer | Fibroblast growth factor | Genes | DNA damage | Medical services | Homology | Malignancy | Criteria | DNA repair | Genetic screening | Homeobox | DNA helicase | Proteins | Ataxia | Genetics | Deoxyribonucleic acid--DNA | Fibroblast growth factor receptor 3 | BRCA2 protein | CHK2 protein | Nucleotide sequence | BRCA1 protein | MLH1 protein | Health risks | Protein C | Breast cancer | Medical screening | Patients | Medical prognosis | Men | Ataxia telangiectasia mutated protein | Mutation | Prostate | Cancer | Fibroblast growth factor receptors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 12/2015, Volume 121, Issue 24, pp. 4382 - 4388
Journal Article
Nature Structural and Molecular Biology, ISSN 1545-9993, 07/2016, Volume 23, Issue 7, pp. 647 - 655
The opposing activities of 53BP1 and BRCA1 influence pathway choice in DNA double-strand-break repair. How BRCA1 counteracts the inhibitory effect of 53BP1 on... 
STRAND BREAK REPAIR | RING-RING COMPLEX | TUMOR SUPPRESSION | BIOCHEMISTRY & MOLECULAR BIOLOGY | REPAIR PATHWAY CHOICE | BRCA1 | REMODELING ENZYME | CELL BIOLOGY | E3 LIGASE | BIOPHYSICS | END RESECTION | HOMOLOGOUS RECOMBINATION | FUN30 | Chromatin - metabolism | DNA, Neoplasm - metabolism | Humans | Gene Expression Regulation, Neoplastic | Ubiquitin - metabolism | DNA Breaks, Double-Stranded | Ubiquitination - drug effects | BRCA1 Protein - metabolism | Tumor Suppressor Proteins - genetics | Cloning, Molecular | Escherichia coli - metabolism | Binding Sites | Chromatin - drug effects | DNA Helicases - genetics | Chromatin - chemistry | Tumor Suppressor p53-Binding Protein 1 - metabolism | Recombinant Proteins - metabolism | Gene Expression | Recombinational DNA Repair | Tumor Suppressor Proteins - metabolism | Tumor Suppressor p53-Binding Protein 1 - genetics | Signal Transduction | Ubiquitin-Protein Ligases - metabolism | Models, Molecular | Recombinant Proteins - genetics | Ubiquitin - genetics | Piperazines - pharmacology | DNA Cleavage - drug effects | BRCA1 Protein - genetics | DNA Helicases - metabolism | Phthalazines - pharmacology | Histones - genetics | Escherichia coli - genetics | Protein Binding | DNA, Neoplasm - genetics | HeLa Cells | Histones - metabolism | Ubiquitin-Protein Ligases - genetics | Camptothecin - pharmacology | Breast cancer | BRCA mutations | DNA repair | Analysis | Risk factors | Enzymes | Protein expression | Chromatin | DNA damage | Index Medicus
Journal Article